ATCC, the premier biological materials resource, services, and standards organization, has been awarded the National Institute of Allergy and Infectious Diseases, Microbiology and Infectious Diseases Biological Resource Repository ("MID-BRR") contract, ATCC announced today. The current value of the contract is $14,615,598 with the ultimate value of $115,733,409 over 7 years with an annual renewal.
“We have key core competencies and resources for biodefense and emerging infections as well as a critical infrastructure in global public health”
The MID-BRR will provide NIAID with a central biorepository for the acquisition, authentication, production, preservation, storage, and distribution of a broad range of unique and quality-assured research materials for the infectious disease research community. It will encompass biodefense, non-biodefense, and emerging infectious disease research materials covering the more than 270 organisms in NIAID's Division of Microbiology and Infectious Disease research portfolio.
"We have provided essential, authenticated biological materials and services to academia, industry and government initiatives for decades. Through this program, ATCC will provide NIAID with the infrastructure for the development and evaluation of vaccines, therapeutics, and diagnostics," said Mary Nicholson, Senior Director BioServices, a division of ATCC.
"All of the services provided by ATCC BioServices are performed under strict quality systems including ISO 9001," said James McArdle, Contract Manager, "and reflect ATCC's leadership position in the standardization of biological materials."
"We have key core competencies and resources for biodefense and emerging infections as well as a critical infrastructure in global public health," said Dr. Raymond Cypess, CEO and President of ATCC. "With more than 85 years of experience under our belt, we are truly a global leader in biological materials management."
Source ATCC
Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy